Gastroenterology Unit, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Dipartimento di Medicina e Chirurgia, Università degli Studi Milano-Bicocca, 20900 Monza, Italy.
Cells. 2023 Jan 19;12(3):370. doi: 10.3390/cells12030370.
Alterations in the human microbiota have been linked to carcinogenesis in several cancers. To date, few studies have addressed the role of the microbiota in cholangiocarcinoma (CCA). Our work aims to update the knowledge about the role of the microbiota in the CCA microenvironment, and to highlight possible novel insights for the development of new diagnostic, prognostic, or even therapeutic strategies. We thus conducted a review of the literature. In recent years, great progress has been made in understanding the pathogenesis, the clinical and histological behavior, and the molecular profile of CCA. Much evidence suggests that the bile microbiota plays an essential role in biliary diseases, including CCA. Some studies have demonstrated that alterations in the qualitative and quantitative composition of the intestinal commensal bacteria lead to overall cancer susceptibility through various pathways. Other studies suggest that the gut microbiota plays a role in the pathogenesis and/or progression of CCA. The clinical implications are far-reaching, and the role of the microbiota in the CCA microenvironment may lead to considering the exciting implications of implementing therapeutic strategies that target the microbiota-immune system axis.
人类微生物组的改变与几种癌症的癌变有关。迄今为止,很少有研究探讨微生物组在胆管癌(CCA)中的作用。我们的工作旨在更新关于微生物组在 CCA 微环境中的作用的知识,并强调为开发新的诊断、预后甚至治疗策略提供可能的新见解。因此,我们对文献进行了综述。近年来,人们在理解 CCA 的发病机制、临床和组织学行为以及分子特征方面取得了很大进展。大量证据表明,胆汁微生物组在包括 CCA 在内的胆道疾病中发挥着重要作用。一些研究表明,肠道共生菌的定性和定量组成的改变通过多种途径导致整体癌症易感性。其他研究表明,肠道微生物组在 CCA 的发病机制和/或进展中发挥作用。其临床意义深远,微生物组在 CCA 微环境中的作用可能导致考虑实施靶向微生物组-免疫系统轴的治疗策略的令人兴奋的影响。